BackEntrada Therapeutics Overview

Entrada Therapeutics Total Current Liabilities

Track Entrada Therapeutics's total current liabilities ($21M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$21.37M
↑ 7.92% YoYΔ $1.57M vs prior year quarter

Peer trimmed avg / median

Loading

Entrada Therapeutics Total Current Liabilities History

Loading

Entrada Therapeutics vs. peers: Total Current Liabilities Comparison

Loading

Entrada Therapeutics Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Entrada Therapeutics (TRDA) FAQ

As of the most recent data (June 2026), TRDA shows a total current liabilities of $21M. That compares with $20M in the prior-year period — up 7.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TRDA's total current liabilities is now $21M (was $20M) — a 7.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Entrada Therapeutics is outperforming or lagging.

Tracking TRDA's total current liabilities over time shows whether Entrada Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $21M That compares with $20M in the prior-year period — up 7.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Entrada Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $21M) with ownership activity and broader fundamentals.